Research funding after COVID-19

Prudêncio, Miguel; Costa, Joana C.

doi:10.1038/s41564-020-0768-z

Cited by 33 publications

(19 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A related concern points to the direction of COVID-19 research dwarfing every other field of research. While this, obviously, should be attributed to the need to come up with a solution against the raging pandemic in a timely fashion, this, potentially, can lead to long term imbalances among scientific fields (Pai, 2020 ; Prudêncio & Costa, 2020 ).…”

Section: Introductionmentioning

confidence: 99%

COVID-19 enabled co-authoring networks: a country-case analysis

Sachini

Sioumalas-Christodoulou

Chrysomallidis

et al. 2021

Scientometrics

View full text Add to dashboard Cite

In this paper we seek to examine the co-authoring pattern of a select group of researchers that are affiliated with a specific country. By way of making use of standard bibliometric analysis, we explore the publication evolution of all COVID-19-related peer reviewed papers that have been (co)-authored by researchers that are affiliated with Greek institutions. The aim is to identify its advancement over time, the institutions involved and the countries with which the co-authors are affiliated with. The timeframe of the study spans from the moment that WHO Director-General declared the novel coronavirus outbreak a public health emergency of international concern (WHO, 2020. Archived: WHO timeline-covid-19. Retrieved from Archived: Who Timeline-COVID-19. https://www.who.int/news/item/27-04-2020-who-timeline---covid-19 . Accessed on 10 May 2020., Archived: WHO timeline-covid-19), January 2020, to October 2020. Findings indicate that there is a steady increase in the number of publications as well as the number of scientific collaborations over time. At a cross-country level, results suggest that the affiliated institutional sectors such as the Higher Education Sector (HES) and the Government Sector (GOV) contributed the most in terms of scientific output. On an international scale, the evolution of the scientific collaboration is imprinted and distributed as a chain of affiliations that linked nations together. Such chains are represented as clusters of countries, in which the scientific connections between different countries can be visualised. It can be reasoned that a significant amount of publications (20%) is affiliated with countries having “traditionally” major scientific impact on the field of Medicine. Supplementary Information The online version contains supplementary material available at 10.1007/s11192-021-03952-9.

show abstract

Section: Introductionmentioning

confidence: 99%

COVID-19 enabled co-authoring networks: a country-case analysis

Sachini

Sioumalas-Christodoulou

Chrysomallidis

et al. 2021

Scientometrics

View full text Add to dashboard Cite

show abstract

“…It is essential to engage research on anti-tropical diseases with a distinct schedule of short, medium and long-term strategies. This is particularly challenging at the present time, since the COVID-19 crisis has significantly shifted both research attention and governmental resources, and that limited human and financial resources can be used to address such tropical diseases and other diseases [ 128 , 129 ].…”

Section: Discussionmentioning

confidence: 99%

Organoboron Compounds: Effective Antibacterial and Antiparasitic Agents

Coghi

Zhu²,

Xie³

et al. 2021

Molecules

View full text Add to dashboard Cite

The unique electron deficiency and coordination property of boron led to a wide range of applications in chemistry, energy research, materials science and the life sciences. The use of boron-containing compounds as pharmaceutical agents has a long history, and recent developments have produced encouraging strides. Boron agents have been used for both radiotherapy and chemotherapy. In radiotherapy, boron neutron capture therapy (BNCT) has been investigated to treat various types of tumors, such as glioblastoma multiforme (GBM) of brain, head and neck tumors, etc. Boron agents playing essential roles in such treatments and other well-established areas have been discussed elsewhere. Organoboron compounds used to treat various diseases besides tumor treatments through BNCT technology have also marked an important milestone. Following the clinical introduction of bortezomib as an anti-cancer agent, benzoxaborole drugs, tavaborole and crisaborole, have been approved for clinical use in the treatments of onychomycosis and atopic dermatitis. Some heterocyclic organoboron compounds represent potentially promising candidates for anti-infective drugs. This review highlights the clinical applications and perspectives of organoboron compounds with the natural boron atoms in disease treatments without neutron irradiation. The main topic focuses on the therapeutic applications of organoboron compounds in the diseases of tuberculosis and antifungal activity, malaria, neglected tropical diseases and cryptosporidiosis and toxoplasmosis.

show abstract

“…Moreover, the most valuable reports may also be rapidly reviewed. Many governmental and private institutions donated funds for research on SARS-CoV-2 and its spread [8][9][10]. Finally, media coverage of scientific progress related to COVID-19 remains intense [11,12].…”

Section: Discussionmentioning

confidence: 99%

The Productivity of Medical Publication on COVID-19 in the First Half of 2020: A Retrospective Analysis of Articles Available in PubMed

Nowak¹,

Kamińśki²

2020

Cureus

View full text Add to dashboard Cite

Background The control of the coronavirus disease 2019 (COVID-19) pandemic depends on the profound investigation of the virus biology and its consequences. We aimed to analyze the COVID-19 research productivity of authors representing different countries and associations between the number of articles and COVID-19 spread. Methods We retrieved all articles on COVID-19 indexed in PubMed between 31 December 2019 and 30 June 2020. We identified the countries of individual authors' affiliations. We performed the R Spearman rank correlation test between the number of articles with at least one author from a country per one million citizens and Human Development Index (HDI), a number of COVID-19 cases and deaths per one million citizens before 1 July 2020. Results Overall, we identified 27,815 articles, including 18,225 original contributions, 2,449 reviews, and 69 metaanalyses on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The highest productivity characterized the authors coming from China (n = 11,519 articles with at least one author), followed by the United States of America (n = 9,666) and Italy (n = 7,261). The number of articles on COVID-19 associated with HDI (Rs = 0.79), the numbers of cases (Rs = 0.47), and deaths (Rs = 0.46) (all p < 0.001). Conclusions Early COVID-19 researches were most often authored by researchers from highly developed countries and those affected by the rapid initial spread of SARS-CoV-2.

show abstract

Research funding after COVID-19

Cited by 33 publications

References 6 publications

COVID-19 enabled co-authoring networks: a country-case analysis

COVID-19 enabled co-authoring networks: a country-case analysis

Organoboron Compounds: Effective Antibacterial and Antiparasitic Agents

The Productivity of Medical Publication on COVID-19 in the First Half of 2020: A Retrospective Analysis of Articles Available in PubMed

Contact Info

Product

Resources

About